V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010110 | 190002979 | 1.64 | 79.6 | Curative (C) | 2015-08-09 | 2015-08-18 | Enzalutamide | 02 | N | DOXORUBICIN | 100128225 |
| 190010111 | 190002980 | 0 | 35.2 | Curative (C) | 2016-02-10 | 2016-02-10 | Cisplatin + Pemetrexed | 02 | N | EW EUROEWING 2012 ARM A VIDE | 101241255 |
| 190010114 | 190002982 | null | null | null | 2019-10-18 | 2019-11-15 | CHOP R - 21 days | null | null | DOXORUBICIN + HD MTX | 101177950 |
| 190010118 | 190002984 | 1.58 | 58 | Adjuvant (A) | 2019-01-21 | 2019-01-27 | EW EuroEwing 2012 Arm B VDC | N | N | EW EUROEWING 2012 ARM B VDC | 100298766 |
| 190010119 | 190002985 | null | null | null | null | 2018-01-12 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 101557171 |
| 190010122 | 190002986 | 1.64 | 62.9 | Palliative (P) | 2019-02-07 | 2019-02-21 | Doxorubicin 75mg/m2 | 02 | N | TRIAL | 100562215 |
| 190010123 | 190002987 | 1.45 | 26 | Palliative (P) | 2016-08-02 | 2016-08-02 | EW EuroEwing 2012 Arm B IE | 01 | null | BLEOMYCIN + CISPLATIN + CYCLOPHOSPHAMIDE + DACTINOMYCIN + ETOPOSIDE + METHOTREXATE + VINCRISTINE | 100042074 |
| 190010127 | 190002990 | null | null | null | null | 2019-01-05 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100767437 |
| 190010128 | 190002991 | null | null | null | 2016-06-24 | 2016-07-09 | ECX | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101335572 |
| 190010129 | 190002992 | null | null | null | null | 2017-04-01 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100420962 |
| 190010131 | 190002993 | 1.66 | 61.2 | Palliative (P) | 2018-08-18 | 2018-08-19 | MAP | N | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101245049 |
| 190010132 | 190002994 | null | null | null | null | 2021-09-21 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100614616 |
| 190010133 | 190002995 | null | null | null | null | 2019-02-01 | BEP 3 day | null | null | TRIAL | 100458479 |
| 190010134 | 190002996 | null | null | null | null | 2017-01-14 | Dox + HD Mtx (post PAM) | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100687466 |
| 190010135 | 190002997 | 1.88 | 82 | null | 2019-03-21 | 2019-03-22 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101260729 |
| 190010137 | 190002998 | null | null | null | null | 2018-03-15 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100807503 |
| 190010145 | 190003000 | null | null | null | null | 2017-02-11 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 100657824 |
| 190010146 | 190003001 | 1.46 | 15.2 | null | null | 2017-10-20 | EW EuroEwing 2012 Arm B VDC | 02 | null | EW EUROEWING 2012 ARM B VDC | 100523946 |
| 190010147 | 190003002 | null | null | null | null | 2018-09-13 | PAM x 2 pre-surgery (cycles 1&2) | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100634253 |
| 190010149 | 190003003 | null | null | null | null | 2016-05-04 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101374283 |
| 190010150 | 190003004 | 1.66 | 85 | Palliative (P) | 2018-03-24 | 2018-04-07 | EOX | 02 | N | NOT MATCHED | 100080628 |
| 190010153 | 190003006 | 0 | 0 | Curative (C) | 2018-04-03 | 2018-04-10 | MAP | null | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100408156 |
| 190010164 | 190003007 | 1.66 | null | Palliative (P) | 2018-09-25 | 2018-09-28 | CHOP R | 02 | N | DOXORUBICIN + METHOTREXATE | 100419330 |
| 190010165 | 190003008 | null | null | null | null | 2018-09-02 | OST Euramos 1 Closed Trial - AP | null | null | OST AP | 100861594 |
| 190010166 | 190003009 | 0 | 73.5 | Adjuvant (A) | 2019-08-09 | 2019-08-09 | OCTREOTIDE | N | N | NOT MATCHED | 100893398 |
| 190010169 | 190003010 | null | null | null | null | 2017-05-25 | OST Euramos 1 Closed Trial - M | null | null | VIDE | 100703440 |
| 190010170 | 190003011 | null | null | null | null | 2018-05-19 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | null | DOXORUBICIN + METHOTREXATE | 101565661 |
| 190010174 | 190003012 | null | null | null | null | 2019-10-21 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100302019 |
| 190010184 | 190003014 | 1.6 | 46.1 | Curative (C) | 2019-02-28 | 2019-03-13 | Trial Unspecified | 02 | N | NB HRNBL-1 COJEC IND COURSE A | 101784800 |
| 190010186 | 190003016 | 1.44 | 0 | Palliative (P) | 2018-11-01 | 2018-11-05 | Cisplatin + Doxorubicin | 02 | N | CISPLATIN + DOXORUBICIN | 100629783 |
| 190010188 | 190003017 | null | null | null | null | 2018-12-23 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101472340 |
| 190010190 | 190003018 | 1.67 | 16.8 | Curative (C) | 2016-06-25 | 2016-06-28 | ECX | 02 | N | NB HRNBL-1 COJEC IND COURSE A | 100306730 |
| 190010196 | 190003019 | null | null | null | null | 2015-06-09 | PAM | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101298542 |
| 190010197 | 190003020 | null | null | null | null | 2018-06-15 | EOX | null | null | DOXORUBICIN + HD MTX | 101144071 |
| 190010203 | 190003021 | 1.74 | 51 | Curative (C) | 2019-11-22 | 2019-11-28 | Doxorubicin 75mg/m2 | N | N | NOT MATCHED | 100229830 |
| 190010207 | 190003022 | null | null | null | null | 2017-04-01 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 101468612 |
| 190010208 | 190003023 | null | null | null | null | 2018-02-27 | CAPECITABINE + OXALIPLATIN | null | null | DOXORUBICIN + METHOTREXATE | 100558816 |
| 190010210 | 190003025 | null | null | null | null | 2017-10-01 | Dox + HD Mtx (post PAM) | null | null | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101445112 |
| 190010212 | 190003026 | null | null | null | null | 2018-05-30 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100469691 |
| 190010215 | 190003027 | null | null | null | null | 2019-07-01 | EW EuroEwing 2012 Arm B VDC | null | null | EW EUROEWING 2012 ARM B VDC | 100957220 |
| 190010216 | 190003028 | 1.65 | 69.8 | Palliative (P) | 2018-07-14 | 2018-07-14 | CARBOPLATIN + RT | 01 | N | EURAMOS TRIAL | 101755258 |
| 190010217 | 190003029 | 1.81 | 92.95 | Neo-adjuvant (N) | 2018-01-05 | 2018-01-05 | EOX | 2 | N | IDARUBICIN | 101209351 |
| 190010230 | 190003031 | null | null | null | null | 2019-07-25 | Dox + HD Mtx (post PAM) | null | null | TRIAL | 101443810 |
| 190010232 | 190003033 | 1.68 | 71 | Curative (C) | 2019-11-09 | 2019-11-09 | EOX | 02 | Y | MAP | 100717091 |
| 190010236 | 190003034 | null | null | null | null | 2016-02-19 | Cisplatin + Doxorubicin | null | null | CISPLATIN + DOXORUBICIN | 101550053 |
| 190010237 | 190003035 | 1.88 | 85.5 | null | 2019-10-16 | 2019-10-17 | EURAMOS TRIAL | 02 | null | GC INT GUIDE EXCRANIAL GERMCELL JEB | 100204635 |
| 190010239 | 190003036 | 1.66 | 63.4 | Palliative (P) | 2017-07-15 | 2017-07-21 | Cisplatin + Doxorubicin | 2 | N | CISPLATIN + DOXORUBICIN | 100041525 |
| 190010245 | 190003037 | 1.78 | 127 | Curative (C) | 2018-05-05 | 2018-05-22 | null | Y | N | EURAMOS TRIAL | 101194627 |
| 190010248 | 190003038 | 1.75 | 60 | Palliative (P) | 2018-11-24 | 2018-11-30 | CISPLATIN + ETOPOSIDE | Y | N | PACLITAXEL | 101158281 |
| 190010250 | 190003039 | null | null | null | null | 2019-01-31 | Cisplatin + Radiotherapy | null | null | CASPS TRIAL | 101719468 |